Improving outcomes of coronary artery bypass graft infections with multiple interventions: putting science and data to the test.
In 2001, 7.58% of our coronary artery bypass graft (CABG) patients developed surgical-site infection (SSI) as compared with 3.57% in National Nosocomial Infections Surveillance System hospitals from January 1992 to June 2001. Seven new preventive measures were implemented and in 2002, the rate was 3.47%. Implementing evidence-based measures improved patient outcomes.
Lutarewych
Michael
M
Southwest Florida Regional Medical Center, Ft. Myers, Florida 33901, USA.
Morgan
Sandra P
SP
Hall
Melanie M
MM
D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001786:Blood Glucose; D015897:Comorbidity; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D003428:Cross Infection / Q000382:microbiology / Q000517:prevention & control*; D048909:Diabetes Complications; D019317:Evidence-Based Medicine; D005260:Female; D005431:Florida; D006801:Humans; D017053:Infection Control / Q000379:methods*; D008297:Male; D016712:Mupirocin / Q000008:administration & dosage; D018571:Sentinel Surveillance; D013530:Surgical Wound Infection / Q000382:microbiology / Q000517:prevention & control*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D001786:Blood Glucose; D016712:Mupirocin